Related references
Note: Only part of the references are listed.Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
Pei Zhu et al.
CANCER PREVENTION RESEARCH (2014)
Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma
Bryan C. Fuchs et al.
HEPATOLOGY (2014)
AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
Jidong Cheng et al.
PLOS ONE (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice
K. Tajima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling
Brendan J. Quinn et al.
CANCER PREVENTION RESEARCH (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Receptor for Advanced Glycation Endproducts (RAGE) Is a Key Regulator of Oval Cell Activation and Inflammation-Associated Liver Carcinogenesis in Mice
Tobias Pusterla et al.
HEPATOLOGY (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
Tomoko Saito et al.
PLOS ONE (2013)
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
Altaf Mohammed et al.
TRANSLATIONAL ONCOLOGY (2013)
Repositioning metformin for cancer prevention and treatment
Brendan J. Quinn et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Kavita Bhalla et al.
CANCER PREVENTION RESEARCH (2012)
Metformin and Cancer Stem Cells: Old Drug, New Targets
Filip Bednar et al.
CANCER PREVENTION RESEARCH (2012)
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival
Craig J. Currie et al.
DIABETES CARE (2012)
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Zhi-Jiang Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma
Wen Yang et al.
JOURNAL OF HEPATOLOGY (2012)
DLK1 as a Potential Target against Cancer Stem/Progenitor Cells of Hepatocellular Carcinoma
Xiao Xu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
Yuki Kita et al.
PLOS ONE (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis
Marianne Ziol et al.
GASTROENTEROLOGY (2010)
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
Xin-Rong Yang et al.
GUT (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
J. Polesel et al.
ANNALS OF ONCOLOGY (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2008)
Advanced glycation end products (AGEs) and their involvement in liver disease
Hideyuki Hyogo et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats
Jin-Rong Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties
Tetsuhiro Chiba et al.
HEPATOLOGY (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
T Roskams
ONCOGENE (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Liver stem cells - Implications for hepatocarcinogenesis
Malcolm R. Alison
STEM CELL REVIEWS (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)